Herbert B Tanowitz Selected Research

Interleukin-17 (Interleukin 17)

5/2016	Suppressor of cytokine signaling 2 modulates the immune response profile and development of experimental cerebral malaria.
8/2014	Role of the aryl hydrocarbon receptor in the immune response profile and development of pathology during Plasmodium berghei Anka infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Herbert B Tanowitz Research Topics

Disease

53	Infections 01/2020 - 02/2002
36	Chagas Disease (American Trypanosomiasis) 03/2018 - 02/2002
20	Cardiomyopathies (Cardiomyopathy) 01/2018 - 02/2002
18	Inflammation (Inflammations) 01/2018 - 06/2005
12	Neoplasms (Cancer) 08/2017 - 10/2006
9	Heart Diseases (Heart Disease) 01/2017 - 08/2002
9	Cerebral Malaria 11/2016 - 07/2005
9	Parasitemia 10/2016 - 03/2010
7	Fibrosis (Cirrhosis) 01/2018 - 02/2008
7	Myocarditis (Carditis) 01/2017 - 06/2002
4	Heart Failure 05/2020 - 01/2009
3	Communicable Diseases (Infectious Diseases) 01/2019 - 11/2014
3	Malaria 11/2018 - 10/2012
3	Breast Neoplasms (Breast Cancer) 06/2016 - 09/2010
3	Sepsis (Septicemia) 01/2016 - 07/2011
3	Prostatic Neoplasms (Prostate Cancer) 08/2010 - 06/2009
2	Hypertrophy 01/2020 - 08/2006
2	Hypoxia (Hypoxemia) 08/2017 - 09/2012
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2016 - 07/2012
2	Chagas Cardiomyopathy 12/2015 - 01/2012
2	Neoplasm Metastasis (Metastasis) 03/2015 - 12/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2013 - 06/2010
2	Hypoglycemia (Reactive Hypoglycemia) 03/2013 - 06/2005
2	Parasitic Diseases (Parasitic Disease) 01/2012 - 01/2009
2	Disease Progression 02/2011 - 01/2011
2	Insulin Resistance 01/2011 - 06/2010
2	Spasm (Spasms) 01/2011 - 08/2002
2	Obesity 10/2010 - 05/2010
2	Carcinogenesis 09/2010 - 05/2010
2	Right Ventricular Hypertrophy 08/2006 - 01/2005
2	Pulmonary Hypertension 08/2006 - 09/2004

Drug/Important Bio-Agent (IBA)

14	Endothelin-1 (Endothelin 1)IBA 01/2019 - 08/2002
14	Proteins (Proteins, Gene)FDA Link 04/2017 - 05/2003
13	CytokinesIBA 01/2020 - 02/2002
10	Caveolin 1IBA 05/2013 - 02/2003
7	ChemokinesIBA 01/2018 - 10/2006
6	Endothelins (Endothelin)IBA 01/2019 - 01/2006
6	Cyclin D1IBA 09/2012 - 05/2003
6	CaveolinsIBA 01/2012 - 09/2004
5	Interleukin-6 (Interleukin 6)IBA 01/2020 - 06/2002
5	Peptides (Polypeptides)IBA 01/2019 - 11/2002
5	DystrophinIBA 01/2017 - 01/2012
5	Pharmaceutical PreparationsIBA 01/2016 - 03/2012
5	AdiponectinIBA 01/2011 - 09/2008
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2016 - 06/2002
4	ThromboxanesIBA 11/2012 - 01/2011
4	Lactic Acid (Lactate)FDA LinkGeneric 09/2012 - 07/2011
4	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2010 - 09/2004
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2002
3	Antiparasitic Agents (Antiparasitics)IBA 11/2018 - 03/2012
3	Insulin (Novolin)FDA Link 03/2017 - 09/2008
3	VaccinesIBA 01/2017 - 10/2006
3	Transcription Factors (Transcription Factor)IBA 10/2016 - 05/2003
3	Connexin 43 (Connexin43)IBA 11/2014 - 01/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2014 - 03/2010
3	Glucose (Dextrose)FDA LinkGeneric 03/2013 - 06/2005
3	Interleukin-10 (Interleukin 10)IBA 11/2012 - 03/2010
3	KetonesIBA 07/2012 - 07/2011
3	Verapamil (Calan)FDA LinkGeneric 03/2012 - 02/2002
3	Glutamine (L-Glutamine)FDA Link 12/2011 - 07/2011
3	SeleniumIBA 03/2011 - 05/2010
3	DNA (Deoxyribonucleic Acid)IBA 08/2010 - 05/2003
3	PPAR gammaIBA 06/2010 - 09/2008
2	Glycoproteins (Glycoprotein)IBA 01/2020 - 01/2017
2	AntioxidantsIBA 03/2018 - 08/2015
2	EnzymesIBA 01/2018 - 01/2011
2	Doxycycline (Periostat)FDA LinkGeneric 08/2017 - 03/2015
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 10/2016 - 08/2014
2	Interleukin-17 (Interleukin 17)IBA 05/2016 - 08/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2016 - 03/2015
2	Adenosine Triphosphate (ATP)IBA 01/2016 - 12/2011
2	CholesterolIBA 10/2014 - 03/2012
2	LipidsIBA 10/2014 - 01/2011
2	Interferon-gamma (Interferon, gamma)IBA 08/2014 - 06/2002
2	Vasoconstrictor AgentsIBA 04/2013 - 05/2003
2	Thromboxane A2 (A2, Thromboxane)IBA 04/2013 - 04/2007
2	Blood Glucose (Blood Sugar)IBA 03/2013 - 10/2012
2	Antimalarials (Antimalarial Agents)IBA 10/2012 - 12/2010
2	CarcinogensIBA 09/2012 - 09/2010
2	A-Form DNA (A-DNA)IBA 07/2012 - 10/2006
2	Mitogen-Activated Protein KinasesIBA 03/2012 - 09/2004
2	BradykininIBA 03/2012 - 05/2003
2	Thromboxane Receptors (Thromboxane Receptor)IBA 04/2011 - 04/2007
2	ProstaglandinsIBA 02/2011 - 01/2011
2	Immunologic Factors (Immunomodulators)IBA 02/2011 - 01/2011
2	EicosanoidsIBA 02/2011 - 01/2011
2	AdipokinesIBA 01/2011 - 07/2009
2	Chemokine CCL5IBA 08/2010 - 03/2010
2	Cyclin EIBA 05/2010 - 10/2006
2	Caveolin 3IBA 04/2010 - 10/2002
2	Endothelin Receptors (Endothelin Receptor)IBA 03/2010 - 06/2006
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 06/2009 - 10/2006
2	Phosphotransferases (Kinase)IBA 10/2006 - 02/2003
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2006 - 09/2004
2	Cell Cycle ProteinsIBA 10/2006 - 01/2006
2	Endothelin-Converting EnzymesIBA 06/2006 - 08/2002
2	CyclinsIBA 01/2006 - 01/2006

Therapy/Procedure

18	Therapeutics 03/2018 - 02/2008
3	Transplantation 05/2011 - 02/2008
2	Heart Transplantation (Grafting, Heart) 03/2012 - 05/2009